What does this research mean for the field?

Angiotensin II mediates cardiovascular disease pathophysiology through complex AT1 receptor signaling networks, including the transactivation of growth factor receptors, Rho/ROCK pathways, and the modulation of endothelial nitric oxide signaling. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To review novel molecular mechanisms of angiotensin II type-1 receptor intracellular signal transduction and their specific contributions to cardiovascular disease pathogenesis.

March 13, 2007Clinical Science

Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology

View Full Paper

Ask AI

Bookmark

Population

Cardiovascular cells, including vascular smooth muscle cells (VSMCs) and endothelial cells

Design

Review

Authors

SHSadaharu HiguchiTokyo Women's Medical University HOHaruhiko OhtsuNational Agriculture and Food Research Organization HSHiroyuki SuzukiTohoku University

Discussion

Member takes

Implication

Supports targeted AT1 inhibition in vascular disease; extends mechanistic insights while leaving clinical translation open.

Key Points

To review novel molecular mechanisms of angiotensin II type-1 receptor intracellular signal transduction and their specific contributions to cardiovascular disease pathogenesis.
Literature synthesis examining angiotensin II signal transduction mediated by the G-protein-coupled AT1 receptor in vascular smooth muscle and endothelial cells.
Evaluation of downstream signaling networks, including small G-proteins, growth factor receptor transactivation, and AT1-receptor-interacting regulatory proteins.
AT1 receptor activation stimulates small G-proteins (Ras, Rho, Rac) and transactivates the epidermal growth factor receptor to drive vascular smooth muscle cell growth, migration, and structural remodeling.
Rho and its effector Rho-kinase mediate pathological cellular actions of angiotensin II in vascular smooth muscle cells.
Endothelial angiotensin II signaling bidirectionally modulates nitric oxide pathways to promote endothelial dysfunction, influenced by selective AT1-receptor-interacting proteins.

Structured PICO

Population

Cardiovascular cells, including vascular smooth muscle cells (VSMCs) and endothelial cells

Intervention

Angiotensin II (AngII) signaling through the AT1 receptor

Outcome

Mechanisms of cardiovascular disease formation (hypertension, atherosclerosis, restenosis)

This review elucidates the complex intracellular signaling pathways of the AT1 receptor, providing mechanistic insights into how Angiotensin II contributes to cardiovascular diseases.

Cite This Study

Higuchi et al. (2007) studied this question.

synapsesocial.com/papers/6a1be8fbfc87fd06169cea75 https://doi.org/10.1042/cs20060342

View Full Paper

Ask AI

Bookmark

Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Also Consider